V029-2275 Screening compound: (2E)-3-phenyl-N-(2-phenylethyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)prop-2-enamide

V029-2275 Screening compound: (2E)-3-phenyl-N-(2-phenylethyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)prop-2-enamide
V029-2275 Screening compound: (2E)-3-phenyl-N-(2-phenylethyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-2275
(2E)-3-phenyl-N-(2-phenylethyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-2275

Molecular Formula

C28H24F3N3O2 (C28 H24 F3 N3 O2)

Compound Name

(2E)-3-phenyl-N-(2-phenylethyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)prop-2-enamide

IUPAC name

(2E)-3-phenyl-N-(2-phenylethyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-124-oxadiazol-5-yl}ethyl)prop-2-enamide

SMILES

O=C(/C=C/c1ccccc1)N(CCc1nc(-c2ccc(C(F)(F)F)cc2)no1)CCc1ccccc1

InChI

InChI=1S/C28H24F3N3O2/c29-28(30,31)24-14-12-23(13-15-24)27-32-25(36-33-27)18-20-34(19-17-22-9-5-2-6-10-22)26(35)16-11-21-7-3-1-4-8-21/h1-16H,17-20H2

InChI Key

XPQPBWNMNKERIE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19778232

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

491.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.613

Distribution Coefficient, logD

6.613

Water Solubility, LogSw

-6.23

Polar Surface Area

46.950

Acid Dissociation Constant (pKa)

26.44

Base Dissociation Constant (pKb)

2.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.90

V029-2275 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with V029-2275 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-2275?
Check Price and Availability of V029-2275, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-2275 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-2275
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-2275
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-2275 available by request